What is the main business of Biomatgel?

The main business activity of Biomatgel focuses on other research and experimental development on natural sciences and engineering.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on October 27, 2016.

Where is the headquarters located?

The headquarters is located at: ul. Pienista 41F, 94-109 Łódź.

Who is on the management board?

The management board includes: Radosław Aleksander Wach (Member of the Management Board) and Bożena Helena Rokita (President of the Management Board).

What is the share capital?

The share capital of the company is PLN 15,000 (approx. $4,052).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

What revenue was generated?

The company reported a revenue of $12,469 in 2024, which is a decrease of 85.3% compared to 2023.

Is the company profitable?

No, in 2024 the company was not profitable, reporting a net loss of $15,951. For comparison, in 2023 the loss was $9,398, meaning the company increased its loss by 61.2%.

What is the largest operating cost?

The largest operating cost category falls under employee remuneration. This category amounted to $10,684 in 2024, representing 38% of all operating expenses.

Biomatgelsp. z o.o.

Other research and experimental development on natural sciences and engineering

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2016-10-27

Share capital

15,000.00 PLN

Activity description

Biomatgel offers hydrogel and bioactive dressings as well as cosmetics for skin regeneration. Its work also includes polymer nanocarriers and stimulus-responsive hydrogels, and its cosmetics brand is MYURU.

Registered address

ul. Pienista 41F/11, 94-109 Łódź, Poland

Website

biomatgel.pl

Financials

Revenue history (in k)

Filing timeliness

Financial statements were filed on time, on average 27 days early.

202526/06/2026
202426/06/2025
202302/07/2024
202206/07/2023
202111/07/2022
202007/07/2021

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 35.53kMedianUSD 73.59kAverageUSD 3.23m

Net profit

This companyUSD 759.45MedianUSD 68.18AverageUSD 82.15k

Operating costs

This companyUSD 34.38kMedianUSD 76.09kAverageUSD 3.04m

Assets

This companyUSD 184.39kMedianUSD 120.07kAverageUSD 3.90m

Industry

Trademarks

Biomatgel currently holds no active trademarks with the Polish Patent Office. 1 application is pending. The first mark was filed in 2026.

Mark	Number	Classes	Status	Protected until
MYURU(word)	Z.608281	3	Application pending	–

Mark	Protected until
MYURU(word)	–

Authorized Representatives

Radosław Aleksander Wach – Management Board Member

Alicja Klaudia Olejnik – Management Board Member

Bożena Helena Rokita – President of the Management Board

Manner of representation

In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.

Ownership

Owner	Shares	Share value	Stake
Sławomir Sebastian Kadłubowskiage 51	30	$607.78	15%
Bożena Helena Rokitaage 48	30	$607.78	15%
Alicja Rosiakage 80	35	$709.08	17.5%
Piotr Krzysztof Ulańskiage 60	35	$709.08	17.5%
Radosław Aleksander Wachage 55	30	$607.78	15%
Others	40	$810.37	20%

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2016-11-09.

mBank
02 1140 2004 0000 3002 7754 7882

Debt

No entries in the National Debtors Register (KRZ).

Public aid

6 public aid cases recorded, with a total value of $169,395.

Grant date	Purpose	Gross amount	Granting body
Dec 29, 2023	De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)	$12,745$12,745	Fundacja Regionalne Centrum Aktywności Gospodarczej
Sep 23, 2022	De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)	$2,770$2,770	Prezes Polskiej Agencji Rozwoju Przedsiębiorczości
Jun 19, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$1,282$1,282	Prezydent Miasta Łódź

European Funds

Start	Project	EU co-financing	Programme
2019-08-01	Development of a technology for innovative bioactive cosmetics	$152.6K$152,598	Regional Operational Programme of the Łódź Voivodeship for 2014–2020

Competitors

Name	Revenue	Website
Medpolmatsp. z o.o.	$257,948.21	medpolmat.pl
Kolgenisp. z o.o.	$133,912.89	kolgeni.pl
Nantes Plazmasp. z o.o.	$96,383.69	nantes.pl
Bio2materialssp. z o.o.	$14,121.59	bio2materials.com

FAQ

Last updated: 2026-07-11